Taiwan's Kaohsiung Medical University selects Collexis to develop the institution's advanced expert profiling system Collexis' launch into the Asian market to enable major Taiwan University and Medical Center to expand its productivity and networking abilities
Columbia, South Carolina (BUSINESS WIRE) - Collexis Holdings, Inc. (OTCBB: CLXS), a leading developer of high definition search and knowledge discovery software, announced today that Kaohsiung Medical University (KMU) has selected the company to develop an Advanced Expert Profiling System that will allow its students, faculty and researchers to connect via a Web interface and help maximize productivity and networking abilities for its combined student, faculty and staff population of more than 15,000.
"Our goal is to provide KMU - a leading medical university in Asia - with a progressive expert profiling system that is specifically tailored to meet their current and future needs," said Bill Kirkland, CEO of Collexis Holdings, Inc. "We're confident this endeavor will serve as a mutually beneficial relationship, helping open doors for Collexis and KMU to facilitate Chinese language-based healthcare and life sciences activities and explore opportunities for future collaboration within specific fields of biomedical research. What's more, our work with KMU will help expand our marketing opportunities throughout the Asian market."
KMU selected Collexis for its ability to enhance research and teaching capabilities, identify areas of productive partnerships and improve such partnerships both on and off the campus. Other benefits include the facilitation of further recruitment and team building, achieving the ultimate goals of improving the overall competitiveness of the University and helping attain professional excellence.
Dr. Por Lai, managing director for Dephoron Co., Ltd. and an exclusive sales agent for Collexis in the Asia Pacific region, played an instrumental role in helping bring KMU together with Collexis. An outstanding alumnus of KMU, Lai is an experienced life sciences professional who previously served as a manager at Sequemat, Amgen and Centocor from 1981 to 1990. He also co-founded the Kirin Pharmaceuticals Co., Ltd. with Kirin Brewery of Japan and developed its biopharmaceutical markets in China, Hong Kong and Taiwan.
"We're excited to work closely with the Collexis team as they develop an advanced expert profiling system for our university," said Hsin-Su Yu, M.D., Ph.D, president of Kaohsiung Medical University. "By helping improve our opportunities for enhanced research capabilities and collaboration, Collexis' innovative technology will also help better position KMU as a significant leader in professional education and services. Working together with Collexis' Knowledge Guide System, we will be able to make more important research contributions to environmental medicine as well as other health-related sciences, and seek more international counterpart cooperation," continued Yu.
KMU joins other prestigious institutions that are also using Collexis' Advanced Expert Profiling System, including Johns Hopkins University, the Mayo Clinic, the National Institutes of Health and the Dana-Farber/Harvard Cancer Center.
About Kaohsiung Medical University
KMU was the first private institution of its kind in Taiwan and was founded in 1954 by former Kaohsiung Mayor Frank C. Chen, along with the first college president, Professor Tu. They established a school with the philosophy of "Joyfully embracing, learning and putting research first, as well as resolutely striving for progress, encouraging study and benefitting the world."
According to Web of Science & Essential Scientific Indicators, KMU ranked 75th in the world in Pharmacology and Toxicology and 387th in the world in clinical medicine during 1997-2007. Today, KMU has transformed into a major medical center home to a 2,000-bed medical center, six colleges, thousands of students and almost 500 researchers. With 25 graduate schools, seven of which offer Ph.D. programs, KMU focuses not only on medical treatment and the management of national health, but is also working toward becoming the leading South Taiwan Medical facility.
About Collexis Holdings, Inc.
Collexis Holdings, Inc., a leading developer of high definition search and knowledge discovery software since 1999, headquartered in Columbia, South Carolina (USA) with major operations in Cincinnati, Ohio, Geldermalsen, the Netherlands and Cologne, Germany. Collexis now offers the world's first pre-populated professional social network for life science researchers, www.biomedexperts.com.
Collexis' proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, Websites, emails and other digitized content and matches them with a comprehensive list of pre-defined "fingerprinted" concepts to make research results more relevant and efficient.
This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as "finding needles in many haystacks." Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect.
Collexis' current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; the University of California, San Francisco; the University of South Carolina; Erasmus University Library; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. Shares of Collexis common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, visit www.collexis.com.
Forward-Looking Statements
Some of the statements made in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements are based on management's current expectations and include known and unknown risks, uncertainties and other factors, many of which the company is unable to predict or control, that may cause the company's actual results or performance to differ materially from any future results or performance expressed or implied by such forward-looking statements.
These statements involve risks and uncertainties, including risks and uncertainties associated with the announcement to develop an expert profiling system for KMU. These risks and uncertainties are in addition to other factors detailed from time to time in the company's filings with the SEC, including the section entitled "Risk Factors" in its transition report on Form 10-KSB for the period ended June 30, 2007, as amended.
The company cautions investors that any forward-looking statements made by the company are not necessarily indicative of future performance. The company is not responsible for updating the information contained in this press release beyond the published date, or for changes made to this document by wire services or Internet services.
Collexis Holdings, Inc. Darrell W. Gunter EVP/CMO Mobile, +1-973-454-3475 Office, +1-803-727-1113 gunter@collexis.com or Media Contact: Chernoff Newman Stephanie Jones, +1-803-233-2432 stephanie.jones@cnsg.com
Columbia, South Carolina (BUSINESS WIRE) - Collexis Holdings, Inc. (OTCBB: CLXS), a leading developer of high definition search and knowledge discovery software, announced today that Kaohsiung Medical University (KMU) has selected the company to develop an Advanced Expert Profiling System that will allow its students, faculty and researchers to connect via a Web interface and help maximize productivity and networking abilities for its combined student, faculty and staff population of more than 15,000.
"Our goal is to provide KMU - a leading medical university in Asia - with a progressive expert profiling system that is specifically tailored to meet their current and future needs," said Bill Kirkland, CEO of Collexis Holdings, Inc. "We're confident this endeavor will serve as a mutually beneficial relationship, helping open doors for Collexis and KMU to facilitate Chinese language-based healthcare and life sciences activities and explore opportunities for future collaboration within specific fields of biomedical research. What's more, our work with KMU will help expand our marketing opportunities throughout the Asian market."
KMU selected Collexis for its ability to enhance research and teaching capabilities, identify areas of productive partnerships and improve such partnerships both on and off the campus. Other benefits include the facilitation of further recruitment and team building, achieving the ultimate goals of improving the overall competitiveness of the University and helping attain professional excellence.
Dr. Por Lai, managing director for Dephoron Co., Ltd. and an exclusive sales agent for Collexis in the Asia Pacific region, played an instrumental role in helping bring KMU together with Collexis. An outstanding alumnus of KMU, Lai is an experienced life sciences professional who previously served as a manager at Sequemat, Amgen and Centocor from 1981 to 1990. He also co-founded the Kirin Pharmaceuticals Co., Ltd. with Kirin Brewery of Japan and developed its biopharmaceutical markets in China, Hong Kong and Taiwan.
"We're excited to work closely with the Collexis team as they develop an advanced expert profiling system for our university," said Hsin-Su Yu, M.D., Ph.D, president of Kaohsiung Medical University. "By helping improve our opportunities for enhanced research capabilities and collaboration, Collexis' innovative technology will also help better position KMU as a significant leader in professional education and services. Working together with Collexis' Knowledge Guide System, we will be able to make more important research contributions to environmental medicine as well as other health-related sciences, and seek more international counterpart cooperation," continued Yu.
KMU joins other prestigious institutions that are also using Collexis' Advanced Expert Profiling System, including Johns Hopkins University, the Mayo Clinic, the National Institutes of Health and the Dana-Farber/Harvard Cancer Center.
About Kaohsiung Medical University
KMU was the first private institution of its kind in Taiwan and was founded in 1954 by former Kaohsiung Mayor Frank C. Chen, along with the first college president, Professor Tu. They established a school with the philosophy of "Joyfully embracing, learning and putting research first, as well as resolutely striving for progress, encouraging study and benefitting the world."
According to Web of Science & Essential Scientific Indicators, KMU ranked 75th in the world in Pharmacology and Toxicology and 387th in the world in clinical medicine during 1997-2007. Today, KMU has transformed into a major medical center home to a 2,000-bed medical center, six colleges, thousands of students and almost 500 researchers. With 25 graduate schools, seven of which offer Ph.D. programs, KMU focuses not only on medical treatment and the management of national health, but is also working toward becoming the leading South Taiwan Medical facility.
About Collexis Holdings, Inc.
Collexis Holdings, Inc., a leading developer of high definition search and knowledge discovery software since 1999, headquartered in Columbia, South Carolina (USA) with major operations in Cincinnati, Ohio, Geldermalsen, the Netherlands and Cologne, Germany. Collexis now offers the world's first pre-populated professional social network for life science researchers, www.biomedexperts.com.
Collexis' proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, Websites, emails and other digitized content and matches them with a comprehensive list of pre-defined "fingerprinted" concepts to make research results more relevant and efficient.
This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as "finding needles in many haystacks." Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect.
Collexis' current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; the University of California, San Francisco; the University of South Carolina; Erasmus University Library; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. Shares of Collexis common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, visit www.collexis.com.
Forward-Looking Statements
Some of the statements made in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
These forward-looking statements are based on management's current expectations and include known and unknown risks, uncertainties and other factors, many of which the company is unable to predict or control, that may cause the company's actual results or performance to differ materially from any future results or performance expressed or implied by such forward-looking statements.
These statements involve risks and uncertainties, including risks and uncertainties associated with the announcement to develop an expert profiling system for KMU. These risks and uncertainties are in addition to other factors detailed from time to time in the company's filings with the SEC, including the section entitled "Risk Factors" in its transition report on Form 10-KSB for the period ended June 30, 2007, as amended.
The company cautions investors that any forward-looking statements made by the company are not necessarily indicative of future performance. The company is not responsible for updating the information contained in this press release beyond the published date, or for changes made to this document by wire services or Internet services.
Collexis Holdings, Inc. Darrell W. Gunter EVP/CMO Mobile, +1-973-454-3475 Office, +1-803-727-1113 gunter@collexis.com or Media Contact: Chernoff Newman Stephanie Jones, +1-803-233-2432 stephanie.jones@cnsg.com
No comments:
Post a Comment